Skip to content
WeighLab

Gimme Care vs NextMeds

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

NextMeds

Provider comparison

Shoppers who will call out and verify the exact price at checkout, given the site shows several different promo numbers at once.

Semaglutide / month
$49/moDated enrollment offer, all doses, compounded; ends October 31
Tirzepatide / month
$119/moDated enrollment offer, all doses, compounded; ends October 31
Index 87/100 · Grade B+Checked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Both score 87/100 on the Cost-Efficiency Index. There is no score winner; compare the treatment you need, billing terms and state availability.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Gimme Care

NextMeds

Semaglutide / month
Gimme Care: $130/mo
NextMeds: $49/moDated enrollment offer, all doses, compounded; ends October 31
Tirzepatide / month
Gimme Care: $163/mo
NextMeds: $119/moDated enrollment offer, all doses, compounded; ends October 31
Semaglutide / year (modeled)
Gimme Care: $1,560
NextMeds: $588
Tirzepatide / year (modeled)
Gimme Care: $1,956
NextMeds: $1,428
State availability
Gimme Care: All 50 states
NextMeds: All 50 states
Oral / sublingual option listed
Gimme Care: Not listed
NextMeds: Not listed
Brand-name access listed
Gimme Care: Not confirmed
NextMeds: Yes
Provider facts checked
Gimme Care: See full review
NextMeds: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Gimme Care

Budget-conscious shoppers who want both molecules disclosed, nationwide access, and pharmacy verification without a premium.

Reasons to consider it

  • Low published prices on both molecules — $130 semaglutide / $163 tirzepatide
  • Nationwide all-50 availability with both molecules disclosed
  • LegitScript-certified pharmacy behind the program

What to weigh up

  • Compounded only — no brand-name or oral options
  • Lower-profile brand with a thinner public track record

NextMeds

Shoppers who will call out and verify the exact price at checkout, given the site shows several different promo numbers at once.

Reasons to consider it

  • Publishes a dated drug-category enrollment offer
  • Names OpenLoop Healthcare Partners and four dispensing partners
  • Telehealth consultations, prescribed medication and shipping included

What to weigh up

  • The enrollment offer ends October 31 at midnight; confirm the timezone and ongoing charge
  • Brand-name products have no public price
  • Refunds are restricted to medical disqualification

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Gimme CareNextMeds
Normalized Cost/Month
Gimme Care:
90/100
NextMeds:
97/100
Price Transparency
Gimme Care:
87/100
NextMeds:
97/100
Nationwide Access
Gimme Care:
96/100
NextMeds:
86/100
Formulation Options
Gimme Care:
78/100
NextMeds:
79/100
Clinical Oversight
Gimme Care:
87/100
NextMeds:
83/100
Contract Flexibility
Gimme Care:
84/100
NextMeds:
67/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.